Better Medicines, Better Life. Everest Medicines is a Hong Kong-listed (HKEX 1952.HK) biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Greater China and other Asian Pacific markets.

云顶新耀是一家在香港上市（HKEX 1952.HK），专注于创新药和疫苗研发、临床开发、制造及商业化的生物制药公司，致力于满足大中华区和其他亚洲市场尚未满足的医疗需求。 Your browser does not support the video tag.

Everest Medicines is a Hong Kong-listed (HKEX 1952.HK) biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in China and other Asian Pacific markets.

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories.

Dec 17, 2024 · Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active ...

Mar 6, 2025 · EVM16 is a novel personalized therapeutic mRNA cancer vaccine internally developed by Everest. It contains neoantigens with high immunogenicity potential, predicted based on the unique tumor...

May 14, 2024 · Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative ...

Dec 17, 2024 · Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company’s core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders.

Mar 7, 2025 · Everest Medicines has dosed the first subject with EVM16, the company’s personalised messenger ribonucleic acid (mRNA) cancer vaccine, in the first-in-human (FIH) trial, EVM16CX01. The dosing procedures took place at Peking University Cancer Hospital in China.

Everest Medicines has achieved technology transfer of the mRNA platform, from mRNA sequence design system, LNP delivery systems to industrial-scale manufacturing at our Jiashan factory.